Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-813160 in Type 2 Diabetes and Diabetic Kidney Disease
NCT01752985Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of BMS-813160 in diabetic kidney disease (DKD), sponsored by Bristol Myers Squibb. Started Mar 2013; status: terminated.
02
Drugs
BMS-813160
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT01752985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01752985.